Gene · 859
Papers2,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Membrane Curvature Generation by the Caveolin 8S Complex and the Role of Cholesterol. | bioRxiv | 2026 | 41727135 | PubTator, text mining | PubMed |
| Corrigendum to <'Caveolin-3 serves as a therapeutic target for myocardial ischemia-reperfusion injury in cardiac surgery patients' Int J Cardiol. 2026 April 15: 449: 134179.>. | Int J Cardiol | 2026 | 41702299 | PubTator, text mining | PubMed |
| Extracellular vesicles at the neuromuscular junction: messengers of synaptic health and disease. | Cell Tissue Res | 2026 | 41686369 | PubTator, text mining | PubMed |
| Role of Caveolae and Caveolin in Vascular Physiology and Pathology. | J Am Heart Assoc | 2026 | 41676939 | PubTator, text mining | PubMed |
| Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis. | Neuropathol Appl Neurobiol | 2026 | 41645489 | PubTator, text mining | PubMed |
| Caveolin-3 serves as a therapeutic target for myocardial ischemia-reperfusion injury in cardiac surgery patients. | Int J Cardiol | 2026 | 41547481 | PubTator, text mining | PubMed |
| CHAMP1 is an essential regulator for human myoblast fusion and muscle development. | Nat Commun | 2026 | 41540007 | PubTator, text mining | PubMed |
| Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944. | J Gen Physiol | 2026 | 41489546 | PubTator, text mining | PubMed |
| Versatile Microfluidics Platform for Enhanced Multitarget Super-Resolution Microscopy. | ACS Nano | 2026 | 41477687 | PubTator, text mining | PubMed |
| Central control of gastrointestinal functions in health and disease. | Physiol Rev | 2026 | 41432726 | PubTator, text mining | PubMed |
| Therapeutic role of caveolin family in stem cell fate and development for management of chronic degenerative diseases: A scientometric study to an in-depth review. | J Adv Res | 2026 | 40554062 | PubTator, text mining | PubMed |
| The non-synthetic sweeteners, miraculin and mogroside V, but not stevia, disrupt the intestinal epithelial barrier function through a sweet taste receptor-dependent mechanism. | Sci Rep | 2025 | 41462549 | PubTator, text mining | PubMed |
| Transmitter and ion channel profiles of saccadic omnipause neurons and cholinergic non-omnipause neurons in human nucleus raphe interpositus. | Front Neuroanat | 2025 | 41403854 | PubTator, text mining | PubMed |
| Assessment of serum caveolin-3 levels in patients with heart failure. | Front Cardiovasc Med | 2025 | 41143172 | PubTator, text mining | PubMed |
| Sphingolipids in Extracellular Vesicles Released From the Skeletal Muscle Plasma Membrane Control Muscle Stem Cell Fate During Muscle Regeneration. | J Extracell Vesicles | 2025 | 40984725 | PubTator, text mining | PubMed |
| SoxB1-Mediated Chromatin Remodeling Promotes Sensory Neuron Differentiation in Planarians. | bioRxiv | 2025 | 40950109 | PubTator, text mining | PubMed |
| Persistent Inflammation, Maladaptive Remodeling, and Fibrosis in the Kidney Following Long COVID-like MHV-1 Mouse Model. | Diseases | 2025 | 40863220 | PubTator, text mining | PubMed |
| Prevalence of human T-cell leukemia virus type 1 associated inflammatory myopathies (HAIM) in Salvador, Brazil. | PLoS Negl Trop Dis | 2025 | 40834046 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies TRIM72 as a candidate gene for autosomal recessive limb-girdle muscular dystrophy. | Hum Genomics | 2025 | 40804694 | PubTator, text mining | PubMed |
| Revolutionizing Autoimmune Research: The Role of Caveolin-1. | Immun Inflamm Dis | 2025 | 40778471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/859/papers?page=2